Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant DNA Technology market report explains the definition, types, applications, major countries, and major players of the Recombinant DNA Technology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Roche
GenScript
Novartis
Pfizer Inc
Profacgen
Eli Lilly and Company
Sanofi
GlaxoSmithKline
Novo Nordisk
Amgen
Horizon Discovery Group
New England Biolabs
Biocon
Monsanto Company
Biogen
Cibus
Merck KGaA
By Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
By End-User:
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Recombinant DNA Technology Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Recombinant DNA Technology Outlook to 2028- Original Forecasts
-
2.2 Recombinant DNA Technology Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Recombinant DNA Technology Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Recombinant DNA Technology Market- Recent Developments
-
6.1 Recombinant DNA Technology Market News and Developments
-
6.2 Recombinant DNA Technology Market Deals Landscape
7 Recombinant DNA Technology Raw Materials and Cost Structure Analysis
-
7.1 Recombinant DNA Technology Key Raw Materials
-
7.2 Recombinant DNA Technology Price Trend of Key Raw Materials
-
7.3 Recombinant DNA Technology Key Suppliers of Raw Materials
-
7.4 Recombinant DNA Technology Market Concentration Rate of Raw Materials
-
7.5 Recombinant DNA Technology Cost Structure Analysis
-
7.5.1 Recombinant DNA Technology Raw Materials Analysis
-
7.5.2 Recombinant DNA Technology Labor Cost Analysis
-
7.5.3 Recombinant DNA Technology Manufacturing Expenses Analysis
8 Global Recombinant DNA Technology Import and Export Analysis (Top 10 Countries)
-
8.1 Global Recombinant DNA Technology Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Recombinant DNA Technology Export by Region (Top 10 Countries) (2017-2028)
9 Global Recombinant DNA Technology Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant DNA Technology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Therapeutic Agent Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Biotech Crops Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Specialty Chemicals Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant DNA Technology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biotechnology and Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Academic & Government Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Recombinant DNA Technology Market Analysis and Outlook till 2022
-
10.1 Global Recombinant DNA Technology Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Recombinant DNA Technology Consumption (2017-2022)
-
10.2.2 Canada Recombinant DNA Technology Consumption (2017-2022)
-
10.2.3 Mexico Recombinant DNA Technology Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Recombinant DNA Technology Consumption (2017-2022)
-
10.3.2 UK Recombinant DNA Technology Consumption (2017-2022)
-
10.3.3 Spain Recombinant DNA Technology Consumption (2017-2022)
-
10.3.4 Belgium Recombinant DNA Technology Consumption (2017-2022)
-
10.3.5 France Recombinant DNA Technology Consumption (2017-2022)
-
10.3.6 Italy Recombinant DNA Technology Consumption (2017-2022)
-
10.3.7 Denmark Recombinant DNA Technology Consumption (2017-2022)
-
10.3.8 Finland Recombinant DNA Technology Consumption (2017-2022)
-
10.3.9 Norway Recombinant DNA Technology Consumption (2017-2022)
-
10.3.10 Sweden Recombinant DNA Technology Consumption (2017-2022)
-
10.3.11 Poland Recombinant DNA Technology Consumption (2017-2022)
-
10.3.12 Russia Recombinant DNA Technology Consumption (2017-2022)
-
10.3.13 Turkey Recombinant DNA Technology Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Recombinant DNA Technology Consumption (2017-2022)
-
10.4.2 Japan Recombinant DNA Technology Consumption (2017-2022)
-
10.4.3 India Recombinant DNA Technology Consumption (2017-2022)
-
10.4.4 South Korea Recombinant DNA Technology Consumption (2017-2022)
-
10.4.5 Pakistan Recombinant DNA Technology Consumption (2017-2022)
-
10.4.6 Bangladesh Recombinant DNA Technology Consumption (2017-2022)
-
10.4.7 Indonesia Recombinant DNA Technology Consumption (2017-2022)
-
10.4.8 Thailand Recombinant DNA Technology Consumption (2017-2022)
-
10.4.9 Singapore Recombinant DNA Technology Consumption (2017-2022)
-
10.4.10 Malaysia Recombinant DNA Technology Consumption (2017-2022)
-
10.4.11 Philippines Recombinant DNA Technology Consumption (2017-2022)
-
10.4.12 Vietnam Recombinant DNA Technology Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Recombinant DNA Technology Consumption (2017-2022)
-
10.5.2 Colombia Recombinant DNA Technology Consumption (2017-2022)
-
10.5.3 Chile Recombinant DNA Technology Consumption (2017-2022)
-
10.5.4 Argentina Recombinant DNA Technology Consumption (2017-2022)
-
10.5.5 Venezuela Recombinant DNA Technology Consumption (2017-2022)
-
10.5.6 Peru Recombinant DNA Technology Consumption (2017-2022)
-
10.5.7 Puerto Rico Recombinant DNA Technology Consumption (2017-2022)
-
10.5.8 Ecuador Recombinant DNA Technology Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Recombinant DNA Technology Consumption (2017-2022)
-
10.6.2 Kuwait Recombinant DNA Technology Consumption (2017-2022)
-
10.6.3 Oman Recombinant DNA Technology Consumption (2017-2022)
-
10.6.4 Qatar Recombinant DNA Technology Consumption (2017-2022)
-
10.6.5 Saudi Arabia Recombinant DNA Technology Consumption (2017-2022)
-
10.6.6 United Arab Emirates Recombinant DNA Technology Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Recombinant DNA Technology Consumption (2017-2022)
-
10.7.2 South Africa Recombinant DNA Technology Consumption (2017-2022)
-
10.7.3 Egypt Recombinant DNA Technology Consumption (2017-2022)
-
10.7.4 Algeria Recombinant DNA Technology Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Recombinant DNA Technology Consumption (2017-2022)
-
10.8.2 New Zealand Recombinant DNA Technology Consumption (2017-2022)
11 Global Recombinant DNA Technology Competitive Analysis
-
11.1 Roche
-
11.1.1 Roche Company Details
-
11.1.2 Roche Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Roche Recombinant DNA Technology Main Business and Markets Served
-
11.1.4 Roche Recombinant DNA Technology Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 GenScript
-
11.2.1 GenScript Company Details
-
11.2.2 GenScript Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 GenScript Recombinant DNA Technology Main Business and Markets Served
-
11.2.4 GenScript Recombinant DNA Technology Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis
-
11.3.1 Novartis Company Details
-
11.3.2 Novartis Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis Recombinant DNA Technology Main Business and Markets Served
-
11.3.4 Novartis Recombinant DNA Technology Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer Inc
-
11.4.1 Pfizer Inc Company Details
-
11.4.2 Pfizer Inc Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Inc Recombinant DNA Technology Main Business and Markets Served
-
11.4.4 Pfizer Inc Recombinant DNA Technology Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Profacgen
-
11.5.1 Profacgen Company Details
-
11.5.2 Profacgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Profacgen Recombinant DNA Technology Main Business and Markets Served
-
11.5.4 Profacgen Recombinant DNA Technology Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Eli Lilly and Company
-
11.6.1 Eli Lilly and Company Company Details
-
11.6.2 Eli Lilly and Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Eli Lilly and Company Recombinant DNA Technology Main Business and Markets Served
-
11.6.4 Eli Lilly and Company Recombinant DNA Technology Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sanofi
-
11.7.1 Sanofi Company Details
-
11.7.2 Sanofi Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sanofi Recombinant DNA Technology Main Business and Markets Served
-
11.7.4 Sanofi Recombinant DNA Technology Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GlaxoSmithKline
-
11.8.1 GlaxoSmithKline Company Details
-
11.8.2 GlaxoSmithKline Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GlaxoSmithKline Recombinant DNA Technology Main Business and Markets Served
-
11.8.4 GlaxoSmithKline Recombinant DNA Technology Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novo Nordisk
-
11.9.1 Novo Nordisk Company Details
-
11.9.2 Novo Nordisk Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novo Nordisk Recombinant DNA Technology Main Business and Markets Served
-
11.9.4 Novo Nordisk Recombinant DNA Technology Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Amgen
-
11.10.1 Amgen Company Details
-
11.10.2 Amgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Amgen Recombinant DNA Technology Main Business and Markets Served
-
11.10.4 Amgen Recombinant DNA Technology Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Horizon Discovery Group
-
11.11.1 Horizon Discovery Group Company Details
-
11.11.2 Horizon Discovery Group Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Horizon Discovery Group Recombinant DNA Technology Main Business and Markets Served
-
11.11.4 Horizon Discovery Group Recombinant DNA Technology Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 New England Biolabs
-
11.12.1 New England Biolabs Company Details
-
11.12.2 New England Biolabs Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 New England Biolabs Recombinant DNA Technology Main Business and Markets Served
-
11.12.4 New England Biolabs Recombinant DNA Technology Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Biocon
-
11.13.1 Biocon Company Details
-
11.13.2 Biocon Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Biocon Recombinant DNA Technology Main Business and Markets Served
-
11.13.4 Biocon Recombinant DNA Technology Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Monsanto Company
-
11.14.1 Monsanto Company Company Details
-
11.14.2 Monsanto Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Monsanto Company Recombinant DNA Technology Main Business and Markets Served
-
11.14.4 Monsanto Company Recombinant DNA Technology Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Biogen
-
11.15.1 Biogen Company Details
-
11.15.2 Biogen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Biogen Recombinant DNA Technology Main Business and Markets Served
-
11.15.4 Biogen Recombinant DNA Technology Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Cibus
-
11.16.1 Cibus Company Details
-
11.16.2 Cibus Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Cibus Recombinant DNA Technology Main Business and Markets Served
-
11.16.4 Cibus Recombinant DNA Technology Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Merck KGaA
-
11.17.1 Merck KGaA Company Details
-
11.17.2 Merck KGaA Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Merck KGaA Recombinant DNA Technology Main Business and Markets Served
-
11.17.4 Merck KGaA Recombinant DNA Technology Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Recombinant DNA Technology Market Outlook by Types and Applications to 2028
-
12.1 Global Recombinant DNA Technology Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Therapeutic Agent Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Biotech Crops Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Specialty Chemicals Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Recombinant DNA Technology Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Biotechnology and Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Academic & Government Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Recombinant DNA Technology Market Analysis and Outlook to 2028
-
13.1 Global Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.2.2 Canada Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.2.3 Mexico Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.2 UK Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.3 Spain Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.4 Belgium Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.5 France Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.6 Italy Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.7 Denmark Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.8 Finland Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.9 Norway Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.10 Sweden Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.11 Poland Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.12 Russia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.3.13 Turkey Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.2 Japan Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.3 India Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.4 South Korea Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.8 Thailand Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.9 Singapore Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.11 Philippines Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.2 Colombia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.3 Chile Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.4 Argentina Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.6 Peru Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6.3 Oman Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6.4 Qatar Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.7.2 South Africa Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.7.3 Egypt Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.7.4 Algeria Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Recombinant DNA Technology Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Recombinant DNA Technology Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Recombinant DNA Technology
-
Figure of Recombinant DNA Technology Picture
-
Table Global Recombinant DNA Technology Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Recombinant DNA Technology Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Therapeutic Agent Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Biotech Crops Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Chemicals Consumption and Growth Rate (2017-2022)
-
Figure Global Biotechnology and Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Academic & Government Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant DNA Technology Consumption by Country (2017-2022)
-
Table North America Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure United States Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Canada Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Mexico Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure Germany Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure UK Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Spain Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Belgium Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure France Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Italy Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Denmark Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Finland Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Norway Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Sweden Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Poland Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Russia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Turkey Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table APAC Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure China Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Thailand Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Singapore Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Philippines Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table South America Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure Brazil Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Colombia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Chile Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Argentina Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Peru Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table GCC Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure Bahrain Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Oman Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Qatar Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table Africa Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure Nigeria Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure South Africa Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Egypt Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Algeria Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table Oceania Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure Australia Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table Roche Company Details
-
Table Roche Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Recombinant DNA Technology Main Business and Markets Served
-
Table Roche Recombinant DNA Technology Product Portfolio
-
Table GenScript Company Details
-
Table GenScript Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenScript Recombinant DNA Technology Main Business and Markets Served
-
Table GenScript Recombinant DNA Technology Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Recombinant DNA Technology Main Business and Markets Served
-
Table Novartis Recombinant DNA Technology Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Recombinant DNA Technology Main Business and Markets Served
-
Table Pfizer Inc Recombinant DNA Technology Product Portfolio
-
Table Profacgen Company Details
-
Table Profacgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Profacgen Recombinant DNA Technology Main Business and Markets Served
-
Table Profacgen Recombinant DNA Technology Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Recombinant DNA Technology Main Business and Markets Served
-
Table Eli Lilly and Company Recombinant DNA Technology Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Recombinant DNA Technology Main Business and Markets Served
-
Table Sanofi Recombinant DNA Technology Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Recombinant DNA Technology Main Business and Markets Served
-
Table GlaxoSmithKline Recombinant DNA Technology Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Recombinant DNA Technology Main Business and Markets Served
-
Table Novo Nordisk Recombinant DNA Technology Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant DNA Technology Main Business and Markets Served
-
Table Amgen Recombinant DNA Technology Product Portfolio
-
Table Horizon Discovery Group Company Details
-
Table Horizon Discovery Group Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Discovery Group Recombinant DNA Technology Main Business and Markets Served
-
Table Horizon Discovery Group Recombinant DNA Technology Product Portfolio
-
Table New England Biolabs Company Details
-
Table New England Biolabs Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table New England Biolabs Recombinant DNA Technology Main Business and Markets Served
-
Table New England Biolabs Recombinant DNA Technology Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Recombinant DNA Technology Main Business and Markets Served
-
Table Biocon Recombinant DNA Technology Product Portfolio
-
Table Monsanto Company Company Details
-
Table Monsanto Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Monsanto Company Recombinant DNA Technology Main Business and Markets Served
-
Table Monsanto Company Recombinant DNA Technology Product Portfolio
-
Table Biogen Company Details
-
Table Biogen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Recombinant DNA Technology Main Business and Markets Served
-
Table Biogen Recombinant DNA Technology Product Portfolio
-
Table Cibus Company Details
-
Table Cibus Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cibus Recombinant DNA Technology Main Business and Markets Served
-
Table Cibus Recombinant DNA Technology Product Portfolio
-
Table Merck KGaA Company Details
-
Table Merck KGaA Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Recombinant DNA Technology Main Business and Markets Served
-
Table Merck KGaA Recombinant DNA Technology Product Portfolio
-
Figure Global Therapeutic Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotech Crops Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Chemicals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotechnology and Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic & Government Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Table North America Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure Germany Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure China Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure Brazil Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure Australia Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
